Insight Molecular Diagnostics Inc. (IMDX)
NASDAQ: IMDX · Real-Time Price · USD
2.690
+0.200 (8.03%)
Sep 9, 2025, 4:00 PM - Market closed
IMDX Employees
As of December 31, 2024, Insight Molecular Diagnostics had 49 total employees, including 46 full-time and 3 part-time employees. The number of employees increased by 3 or 6.52% compared to the previous year.
Employees
49
Change (1Y)
3
Growth (1Y)
6.52%
Revenue / Employee
$86,878
Profits / Employee
-$1,294,224
Market Cap
76.41M
Employees Chart
Employees History
Date | Employees | Change | Growth |
---|---|---|---|
Dec 31, 2024 | 49 | 3 | 6.52% |
Dec 31, 2023 | 46 | -30 | -39.47% |
Dec 31, 2022 | 76 | -39 | -33.91% |
Dec 31, 2021 | 115 | 64 | 125.49% |
Dec 31, 2020 | 51 | 18 | 54.55% |
Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Dec 31, 2015 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Related Stocks
Company Name | Employees |
---|---|
UnitedHealth Group | 400,000 |
Johnson & Johnson | 138,100 |
Thermo Fisher Scientific | 125,000 |
Abbott Laboratories | 114,000 |
AstraZeneca | 92,900 |
Novo Nordisk | 77,349 |
Novartis AG | 75,883 |
Merck & Co. | 75,000 |
IMDX News
- 2 days ago - Insight Molecular Diagnostics Announces Positive Strategic Update and Novel Registry Database - GlobeNewsWire
- 2 days ago - IMDX Enrolls First Patient in GraftAssureDx Clinical Trial and Welcomes New Hospital Participants - GlobeNewsWire
- 14 days ago - iMDx to Participate in NYC Investment Conferences September 8 - 11 - GlobeNewsWire
- 4 weeks ago - IMDX Reports Q2 2025 Results and Momentum Toward GraftAssureDx Launch - GlobeNewsWire
- 5 weeks ago - iMDx to Release Second Quarter 2025 Results on August 11, 2025 and Attend Needham Virtual MedTech and Diagnostics Conference - GlobeNewsWire
- 5 weeks ago - IMDX World Transplant Congress Late-Breaking Data Potentially Sets New Bar for Predicting Graft Rejection in Kidney Transplant Patients - GlobeNewsWire
- 6 weeks ago - iMDx to Host Virtual KOL Event to Discuss its In-House dd-cfDNA Testing for Kidney Transplant Patients on August 15, 2025 - GlobeNewsWire
- 2 months ago - iMDx Reports Strong Head-to-Head Data in Kidney Transplant Rejection Testing - GlobeNewsWire